Discover
PHIO
Phio Pharmaceuticals Corp.
0.86
2 x 0.69
2 x 1.31
bid
ask
-
0.00
0.30%
2 @ 04:00 PM
0.88 +0.02 (1.94%)
| Ytd | -18.10% | |
| 1y | -58.25% |
0.85
day range
0.88
0.81
52 week range
4.19
| Open | 0.86 | Prev Close | 0.86 | Low | 0.85 | High | 0.88 | Mkt Cap | 9.99M |
| Vol | 66.66K | Avg Vol | 128.05K | EPS | -1.29 | P/E | N/A | Forward P/E | 0.07 |
| Beta | 1.47 | Short Ratio | 0.50 | Inst. Own | 3.02% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.01 | 200-d Avg | 1.09 | 1yr Est | 36.00 |
| Income Statement | |||
| Operating Expenses | 4.27M | ||
| Research and Development Expense | 3.08M | ||
| Selling, General and Administrative Expense | 1.19M | ||
| Operating Income | -4.27M | ||
| Net Income | -4.14M | ||
| Net Income Common Stock | -4.14M | ||
| Net Income Common Stock (USD) | -4.14M | ||
| Consolidated Income | -4.14M | ||
| Earnings per Basic Share | -0.36 | ||
| Earnings per Basic Share (USD) | -0.36 | ||
| Earnings per Diluted Share | -0.36 | ||
| Earning Before Interest & Taxes (EBIT) | -4.14M | ||
| Earning Before Interest & Taxes (USD) | -4.14M | ||
| Weighted Average Shares | 11.62M | ||
| Weighted Average Shares Diluted | 11.62M | ||
| Balance Sheet | |||
| Cash and Equivalents | 13.00M | ||
| Cash and Equivalents (USD) | 13.00M | ||
| Current Assets | 14.30M | ||
| Property, Plant & Equipment Net | 9.00K | ||
| Total Assets | 14.31M | ||
| Current Liabilities | 1.71M | ||
| Total Liabilities | 1.71M | ||
| Accumulated Retained Earnings (Deficit) | -163.19M | ||
| Shareholders Equity | 12.60M | ||
| Shareholders Equity (USD) | 12.60M | ||
| Assets Non-Current | 9.00K | ||
| Trade and Non-Trade Payables | 901.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.03M | ||
| Capital Expenditure | 3.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -3.00K | ||
| Net Cash Flow from Operations | -4.03M | ||
| Share Based Compensation | 278.00K | ||